![Thomas Schall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Schall
Chairman at
IMMUNEERING CORPORATION
Net worth: 430 038 $ as of 2026-05-30
Profile
Dr. Thomas J.
Schall is a Chairman at Immuneering Corp.
Dr. Schall was previously employed as a Chairman, President & Chief Executive Officer by ChemoCentryx, Inc., a Principal by DNAX Research Institute of Molecular & Cellular Biology, Inc., and a Scientist by Genentech, Inc. He received his undergraduate degree from Northern Illinois University and a doctorate degree from Stanford University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 74,530 ( 0.12% ) | 430 038 $ | 2026-05-30 |
Thomas Schall active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNEERING CORPORATION | Chairman | 2025-09-15 |
Former positions of Thomas Schall
| Companies | Position | End |
|---|---|---|
| CHEMOCENTRYX, INC. | Chief Executive Officer | 2022-10-19 |
DNAX Research, Inc. | Corporate Officer/Principal | 1996-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Schall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Illinois University
 Northern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
- Stock Market
- Insiders
- Thomas Schall
